Short CV/Education and training

  • 1990
    Abitur (A-levels), Calvarienberg Gymnasium (grammar school), Ahrweiler, Germany

  • 1990 – 1996
    Studied medicine at the Ruhr University Bochum and at Heidelberg University, Germany

  • 1993
    United States Medical Licencing Examination Part 1

  • 1995
    United States Medical Licencing Examination Part 2

  • 1996
    United States Medical Licencing Examination Part 3

  • 1998
    Fully licenced to practise medicine

  • 1999 – 2000
    Research fellow at Children's Hospital & Massachusetts Eye and Ear Infirmary, Harvard Medical School, Boston, USA; topic: The pharmacophysiology of diabetic retinopathy

  • 2002
    venia legendi (authorisation to teach) in the field of ophthalmology. Senior consultant, Department of Retinal and Vitreous Body Surgery

  • 2003
    Senior consultant at the Centre for Ophthalmology, University of Cologne, Germany. Deputy to the director, Department of Retinal and Vitreous Body Surgery

  • 2006
    Offer of a W3 Chair in ophthalmology at Heinrich Heine University, Düsseldorf, Germany (accepted)

  • 2009
    Offer a W3 Chair in ophthalmology at Charité University Medical Centre, Berlin, Germany, including the location at Steglitz and the Virchow Clinic

  • 2010
    Acceptance of professorship and assumption of duties in Berlin

Selected publications

  • Joussen, A.M. et al.: Leukocyte mediated cell injury and death in the diabetic retina. In: Am J Pathol. 158, 2001. S. 147-152.

  • Joussen, A.M. et al.: In vivo retinal gene expression in early diabetes. In: Invest Ophthalmol Vis Sci 42, 2001. S. 3047-3057.

  • Joussen, A.M. et al.: Retinal vascular endothelial growth factor induces intercellular adhesion molecule-1 and endothelial nitric oxide synthase expression and initiates early diabetic retinal leukocyte adhesion in vivo. In: Am J Pathol 160, 2002. S. 501-509.

  • Joussen, A.M. et al.: Suppression of diabetic retinopathy with Angiopoietin-1. In: Am J Pathol 160, 2002. S. 1683-1693.

  • Joussen, A.M. et al.: Nonsteroidal anti-inflammatory drugs prevent early diabetic retinopathy via TNF-a suppression. In: FASEB J 16, 2002. S. 438-440.

  • Joussen, A.M. et al.: Suppression of Fas-FasL induced endothelial cell apoptosis prevents diabetic blood-retinal barrier breakdown in a model of streptozotocin-induced diabetes. In: FASEB J 17, 2003. S. 76-78.

  • Poulaki, V. et al.: Activin A in the regulation of corneal neovascularization and VEGF expression. In: Am J Pathol 164, 2004. S. 1293-1302.

  • Poulaki, V. et al.: Insulin-like growth factor-I plays a pathogenetic role in diabetic retinopathy. In: Am J Pathol. 165(2), 2004. S. 457-469.

  • Joussen, A.M. et al.: A central role for inflammation in the pathogenesis of diabetic retinopathy. In: FASEB J. 18(12), 2004. S. 1450-1452.

  • Semkova, I. et al.: Overexpression of FasL in retinal pigment epithelial cells reduces choroidal neovascularization. In: FASEB J. 20(10), 2006. S. 1689-1691.

Selected projects

  • University of Cologne, Germany: coordination of an interdisciplinary research group on diabetic retinopathy, 2004

  • Centre for Ophthalmology, University of Cologne: director of the retinological research laboratory, head of a project investigating diabetic retinopathy, corneal angiogenesis, vitreous body replacement, oxygen-induced retinopathy, 2001

Membership in scientific bodies/juries

  • Editor in Chief "Graefes Archives of Ophthalmology"


You can only see the contact information of the academics in the database if you are a registered user of AcademiaNet.
Please register here


  1. Read what our members say about AcademiaNet.

No more excuses!

  1. Please download the brochure "No more excuses" and read more about female experts in Europe, and about AcademiaNet.

Similar profiles

  1. Dr. Nicola Allen

    HealthRole of astrocytes in brain function

  2. Prof. Dr. Katrin Amunts

    HealthBrain Research

  3. Dr. Irene Agyepong

    HealthPublic Health

  4. PhD My Andersson

    Biological and related sciences , HealthNeurophysiology (synaptic physiology)